Clinical Trial Update: Efficacy of Nyaditum Resae(R) Against Active TB in Georgia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Nyaditum Resae showing Phase 2/3 evaluation in close contacts of active tuberculosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Nyaditum Resae

Snippet

Sponsor: Fundació Institut Germans Trias i Pujol | Conditions: Close Contacts of Active Tuberculosis | Phase 2, Phase 3 | Status: UNKNOWN